Prior studies demonstrated that leptin stimulates the growth of human breast cancer cells in vitro and promotes angiogenesis via vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGF2) pathways [68]. Here, LEP is linked to breast carcinoma.